En vivo
FierceBiotechBiogen inks $1B RayThera buyout to bag preclinical immunology assetsEndpoints NewsModerna adds commercial chief, expands Stephen Hoge's role; Reunion Neuroscience CEO departsEndpoints NewsEli Lilly's TuneLab hits 100 members, adding Chai's AI modelsCellChloroplast sunscreening by protein condensates confers high-light toleranceFierceBiotechF2G, Shionogi prep regulatory push after novel antifungal passes ph. 3 testEndpoints NewsAntifungal from F2G, Shionogi succeeds in Phase 3 studyRoche MediaPartnering for Sustainable Healthcare: Roche Stands with Taiwan to Build an Innovation-Friendly Biomedical Ecosystem - Taiwan Business TOPICSBioPharma DiveKardigan extends biotech’s streak of big IPOs with $400M haulEndpoints NewsKardigan raises $400M in IPO to back three clinical-stage cardio drugsEndpoints NewsBiogen makes up to $1B deal for secretive anti-inflammatory biotecheLifeConstraints on the G1/S transition pathway may favor selection of multicellularity as a passenger phenotypeFierceBiotech‘We think about it every day’: How Daiichi Sankyo’s R&D chief plans to stay ahead in the ADC game

Archivo

Reciente Más antiguo
Total 13541
Página 121 / 753
Búsqueda --